Pulmonary Vascular and Pleural Diseases

3rd Year MBBS • Respiration

Connect the major mechanisms, pathological changes, clinical clues and basic management principles for rapid revision.

1. THE TOPIC IN ONE CONNECTED FLOW

Pulmonary vascular and pleural diseases disturb either blood flow through the lungs or the normal pleural space surrounding them. The central connection is simple: vascular obstruction or injury changes pulmonary perfusion, while pleural fluid, blood, chyle or air interferes with normal lung expansion. These mechanisms explain the major clinical findings and complications.

Initiating Problem

Venous thrombus, hypoxia, immune vascular injury or pleural disruption

→

Core Mechanism

Vascular obstruction/remodeling or abnormal pleural accumulation

→

Structural Change

Reduced perfusion, hemorrhage/infarction, arterial narrowing or lung collapse

→

Clinical Effect

Dyspnea, pleuritic pain, hypoxemia, reduced breath sounds or hemodynamic compromise

→

Diagnostic Clue

Imaging, pleural fluid pattern or characteristic pathology

→

Intervention / Outcome

Treat underlying cause, drain pleural air when required and prevent major complications

Pulmonary vascular branch

Deep venous thrombus → pulmonary arterial embolization → reduced perfusion ± hemorrhagic infarction → pleuritic pain/hemoptysis. Recurrent obstruction or chronic hypoxic vasoconstriction → vascular remodeling → pulmonary hypertension → right ventricular pressure overload.

Pleural branch

Hydrostatic/oncotic imbalance → transudate; local inflammation or impaired drainage → exudate. Pleural air → pneumothorax and lung recoil; blood → hemothorax; thoracic duct disruption → chylothorax.

2. KEY CLINICAL CONNECTIONS

Pulmonary Embolism → Infarction

Venous thrombus → pulmonary arterial obstruction → impaired perfusion
→
peripheral hemorrhagic infarction when collateral supply is inadequate.

Infarct reaches pleura
→
pleural irritation
→
pleuritic chest pain ± hemoptysis.

Pleural Effusion → Mechanism

Increased hydrostatic pressure or reduced oncotic pressure
→
relatively protein-poor transudate.

Local inflammation or impaired lymphatic drainage
→
protein-rich exudate.

Pneumothorax → Emergency Physiology

Pleural air → loss of negative intrapleural pressure → lung recoil and collapse
→
reduced breath sounds and hyperresonance.

One-way air trapping → rising pleural pressure → reduced venous return
→
hypotension in tension pneumothorax.

3. AIM HIGH-YIELD INTEGRATION REVIEW

⭐ Pulmonary embolism: deep venous thrombus → pulmonary arterial obstruction → acute ventilation-perfusion disturbance and increased pulmonary vascular resistance.

⭐ Pulmonary infarction: arterial occlusion + inadequate collateral perfusion → peripheral hemorrhagic wedge-shaped necrosis → pleuritic pain and possible hemoptysis.

Pulmonary hypertension: persistent vascular stress → medial/intimal remodeling → increased resistance → right ventricular hypertrophy and eventual failure.

Diffuse alveolar hemorrhage: capillary injury → red cells enter alveoli → impaired gas exchange; repeated bleeding → hemosiderin-laden macrophages.

⭐ Transudate vs exudate: systemic hydrostatic/oncotic imbalance → transudate; local inflammation or impaired drainage → exudate.

⭐ Tension pneumothorax: one-way pleural air entry → increasing pressure → lung collapse + impaired venous return → cardiovascular compromise.

Hemothorax: intrapleural blood → lung compression + circulating blood-volume loss, so respiratory and hemodynamic effects may occur together.

Chylothorax: thoracic duct disruption or obstruction → lipid-rich chyle enters pleural space → classically milky pleural fluid.

AIM Exam Trap: Pulmonary hemorrhage does not automatically mean pulmonary infarction. The lung’s dual blood supply may permit hemorrhage without tissue necrosis; infarction develops when blood supply is insufficient to maintain tissue viability.